World's Best Scientists 2026 revealed!
Pasquale Striano

Pasquale Striano

D-Index & Metrics

Neuroscience

D-Index
95
Citations
38432
World Ranking
894
National Ranking
25

Medicine

D-Index
95
Citations
38438
World Ranking
9962
National Ranking
354

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Mutation

The scientist’s investigation covers issues in Epilepsy, Genetics, Pediatrics, Pathology and Mutation. Pasquale Striano studies Idiopathic generalized epilepsy which is a part of Epilepsy. His Genetics study deals with Myoclonic epilepsy intersecting with Genetic counseling, Germline, Somatic cell, Germline mosaicism and Febrile seizure.

His studies deal with areas such as Psychiatry, Encephalopathy, Central nervous system disease, Ictal and Age of onset as well as Pediatrics. Pasquale Striano has researched Pathology in several fields, including Edema, Seizure types, Cortical dysplasia, Gene mutation and Neurology. His work in the fields of Exome overlaps with other areas such as PRRT2 and Paroxysmal dyskinesia.

His most cited work include:

  • Analysis of shared heritability in common disorders of the brain (726 citations)
  • Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes (609 citations)
  • Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations (249 citations)

What are the main themes of his work throughout his whole career to date?

Pasquale Striano mostly deals with Epilepsy, Pediatrics, Genetics, Internal medicine and Electroencephalography. His Epilepsy research is multidisciplinary, relying on both Myoclonus, Neurology and Bioinformatics. His Myoclonus study frequently links to adjacent areas such as Neurological disorder.

His work deals with themes such as Anesthesia, Retrospective cohort study, Ictal, Lennox–Gastaut syndrome and Levetiracetam, which intersect with Pediatrics. His study involves Gene, Missense mutation, Mutation, Phenotype and Exome sequencing, a branch of Genetics. His Internal medicine research includes elements of Gastroenterology and Endocrinology.

He most often published in these fields:

  • Epilepsy (63.34%)
  • Pediatrics (29.18%)
  • Genetics (16.72%)

What were the highlights of his more recent work (between 2019-2021)?

  • Epilepsy (63.34%)
  • Pediatrics (29.18%)
  • Internal medicine (11.58%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Epilepsy, Pediatrics, Internal medicine, Genetics and Dravet syndrome. Pasquale Striano works in the field of Epilepsy, namely Epilepsy syndromes. His Pediatrics research incorporates elements of MEDLINE, Intellectual disability, Lennox–Gastaut syndrome, Levetiracetam and Neurology.

In his research, Concomitant is intimately related to Placebo, which falls under the overarching field of Internal medicine. His work in Genetics covers topics such as Disease which are related to areas like Mutation and Atrophy. His work carried out in the field of Bioinformatics brings together such families of science as Drug resistance, Family history, Cohort and Candidate gene.

Between 2019 and 2021, his most popular works were:

  • Cannabidiol efficacy and clobazam status: A systematic review and meta‐analysis (26 citations)
  • Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety. (26 citations)
  • Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients. (15 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Mutation

Epilepsy, Pediatrics, Internal medicine, Neurology and Dravet syndrome are his primary areas of study. His biological study spans a wide range of topics, including Exome sequencing, Missense mutation and Intellectual disability. The study incorporates disciplines such as Lennox–Gastaut syndrome, Pharmacotherapy, Childhood epilepsy, Re sequencing and Etiology in addition to Pediatrics.

Pasquale Striano studied Internal medicine and Placebo that intersect with Concomitant, Adverse effect, Incidence, Phenytoin and Clinical trial. Pasquale Striano usually deals with Neurology and limits it to topics linked to Neurosurgery and Disease management, Neuroradiology and Comorbidity. His Dravet syndrome research includes themes of Efficacy and Cannabidiol.

Best Publications

  • Analysis of shared heritability in common disorders of the brain

    Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters

  • Mapping the human genetic architecture of COVID-19

    Unknown

  • Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes

    Heather C Mefford;Andrew J Sharp;Carl Baker;Andy Itsara

  • Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.

    Markus Wolff;Katrine M Johannesen;Ulrike B S Hedrich;Silvia Masnada

  • Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study.

    Christopher D Whelan;Christopher D Whelan;Andre Altmann;Juan A Botía;Neda Jahanshad

  • Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies

    Bassel Abou-Khalil;Pauls Auce;Andreja Avbersek;Melanie Bahlo

  • Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations

    E. Parrini;A. Ramazzotti;W. B. Dobyns;D. Mei

  • De novo loss-or gain-of-function mutations in KCNA2 cause epileptic encephalopathy

    Steffen Syrbe;Ulrike B.S. Hedrich;Erik Riesch;Tania Djémié

  • STXBP1 encephalopathy A neurodevelopmental disorder including epilepsy

    Hannah Stamberger;Marina Nikanorova;Marjolein H. Willemsen;Patrizia Accorsi

  • Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export

    Andrea Legati;Donatella Giovannini;Gaël Nicolas;Uriel López-Sánchez

  • De novo variants in neurodevelopmental disorders with epilepsy.

    Henrike O. Heyne;Tarjinder Singh;Tarjinder Singh;Hannah Stamberger;Rami Abou Jamra

  • Posterior reversible encephalopathy syndrome in intensive care medicine.

    Giuseppe Servillo;Francesca Bifulco;Edoardo De Robertis;Ornella Piazza

  • Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies

    Richard Anney;A. Avbersek;D. Balding;L. Baum

  • De Novo Loss-of-Function Mutations in CHD2 Cause a Fever-Sensitive Myoclonic Epileptic Encephalopathy Sharing Features with Dravet Syndrome

    Arvid Suls;Johanna A. Jaehn;Angela Kecskés;Yvonne Weber

  • De novo mutations in HCN1 cause early infantile epileptic encephalopathy

    Caroline Nava;Carine Dalle;Agnès Rastetter;Pasquale Striano

  • Extending the KCNQ2 encephalopathy spectrum Clinical and neuroimaging findings in 17 patients

    S Weckhuysen;Ivanovic;R Hendrickx;Van, Coster, R

  • Posterior reversible encephalopathy syndrome: the endothelial hypotheses.

    A. Marra;M. Vargas;P. Striano;L. Del Guercio

  • AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders

    Vincenzo Salpietro;Vincenzo Salpietro;Vincenzo Salpietro;Christine L Dixon;Hui Guo;Hui Guo;Oscar D Bello

  • Infantile spasms syndrome, West syndrome and related phenotypes: What we know in 2013

    Piero Pavone;Pasquale Striano;Raffaele Falsaperla;Lorenzo Pavone

  • The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies.

    Antonella Fattorusso;Sara Matricardi;Elisabetta Mencaroni;Giovanni Battista Dell'Isola

  • Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures

    Gemma L. Carvill;Jacinta M. McMahon;Amy Schneider;Matthew Zemel

  • Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy

    Maria Paola Canevini;Giovambattista De Sarro;Carlo Andrea Galimberti;Giuliana Gatti

  • Erratum: De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies (American Journal of Human Genetics (2014) 95(4) (360–370)(S0002929714003838)(10.1016/j.ajhg.2014.08.013))

    Silke Appenzeller;Rudi Balling;Nina Barisic;Stéphanie Baulac

Frequent Co-Authors

Federico Zara
Federico Zara University of Genoa
Salvatore Striano
Salvatore Striano University of Naples Federico II
Carlo Minetti
Carlo Minetti University of Genoa
Renzo Guerrini
Renzo Guerrini University of Florence
Pasquale Parisi
Pasquale Parisi Sapienza University of Rome
Ingo Helbig
Ingo Helbig Children's Hospital of Philadelphia
Rikke S. Møller
Rikke S. Møller University of Southern Denmark
Antonio Gambardella
Antonio Gambardella Magna Graecia University
Sarah Weckhuysen
Sarah Weckhuysen University of Antwerp
Giuseppe Capovilla
Giuseppe Capovilla Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Pasquale Striano

Trending Scientists